MTHFR 677 T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: A meta-analysis
Authors:
- Sheng YangSYSheng Yang
- Jingwen ZhangJZJingwen Zhang
- Chang FengCFChang Feng
- Guoliang HuangGHGuoliang Huang
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 62 (4) , 586-594
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Management of type 2 diabetes: new and future developments in treatmentThe Lancet, 2011
- A complex interplay of factors causes diabetic nephropathyMetabolism, 2011
- Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetesMetabolism, 2011
- Genomics, Type 2 Diabetes, and ObesityNew England Journal of Medicine, 2010
- Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathyNephrology Dialysis Transplantation, 2006
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003
- Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2002
- Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?Nephrology Dialysis Transplantation, 1999
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994